Targeting the viral Achilles' heel: Recognition of 5'-triphosphate RNA in innate anti-viral defence

Current Opinion in Microbiology

Volumn 16, Issue 4, 2013, Pages 485-492

  Rehwinkel, Jan ^a   Reis e Sousa, Caetano ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOIC ACID INDUCIBLE PROTEIN I; RNA HELICASE; VIRUS RNA;

BASE PAIRING; GENE TARGETING; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; HEEL; INFLUENZA VIRUS A; INNATE IMMUNITY; MOLECULAR RECOGNITION; NONHUMAN; PROTEIN SECONDARY STRUCTURE; REVIEW; RNA SEQUENCE; SIGNAL TRANSDUCTION;

RNA VIRUSES;

ANIMALS; CARRIER PROTEINS; DEAD-BOX RNA HELICASES; HUMANS; IMMUNITY, INNATE; RNA VIRUSES; RNA, VIRAL; RNA-BINDING PROTEINS;

EID: 84882856566     PISSN: 13695274     EISSN: 18790364     Source Type: Journal    
DOI: 10.1016/j.mib.2013.04.009     Document Type: Review

References (54)

1. Isaacs A., Lindenmann J. Virus interference. I. The interferon. Proc R Soc Lond B Biol Sci 1957, 147:258-267.
2. Pestka S., Krause C.D., Walter M.R. Interferons, interferon-like cytokines, and their receptors. Immunol Rev 2004, 202:8-32.
3. Pichlmair A., Reis e Sousa C. Innate recognition of viruses. Immunity 2007, 27:370-383.
4. Crow Y.J. Type I interferonopathies: a novel set of inborn errors of immunity. Ann N Y Acad Sci 2011, 1238:91-98.
5. Schoggins J.W., Wilson S.J., Panis M., Murphy M.Y., Jones C.T., Bieniasz P., Rice C.M. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 2011, 472:481-485.
6. Fensterl V., Sen G.C. The ISG56/IFIT1 gene family. J Interferon Cytokine Res 2011, 31:71-78.
7. Diamond M.S., Farzan M. The broad-spectrum antiviral functions of IFIT and IFITM proteins. Nat Rev Immunol 2013, 13:46-57.
8. Abbas Y.M., Pichlmair A., Gorna M.W., Superti-Furga G., Nagar B. Structural basis for viral 5'-PPP-RNA recognition by human IFIT proteins. Nature 2013, 494:60-64.
9. Pichlmair A., Lassnig C., Eberle C.A., Gorna M.W., Baumann C.L., Burkard T.R., Burckstummer T., Stefanovic A., Krieger S., Bennett K.L., et al. IFIT1 is an antiviral protein that recognizes 5'-triphosphate RNA. Nat Immunol 2011, 12:624-630.
10. Rehwinkel J., Reis e Sousa C. RIGorous detection: exposing virus through RNA sensing. Science 2010, 327:284-286.
11. Schlee M., Hartmann G. The chase for the RIG-I ligand-recent advances. Mol Ther 2010, 18:1254-1262.
12. Baum A., Sachidanandam R., Garcia-Sastre A. Preference of RIG-I for short viral RNA molecules in infected cells revealed by next-generation sequencing. Proc Natl Acad Sci U S A 2010, 107:16303-16308.
13. Rehwinkel J., Tan C.P., Goubau D., Schulz O., Pichlmair A., Bier K., Robb N., Vreede F., Barclay W., Fodor E., et al. RIG-I detects viral genomic RNA during negative-strand RNA virus infection. Cell 2010, 140:397-408.
14. Weber M., Gawanbacht A., Habjan M., Rang A., Borner C., Schmidt Anna M., Veitinger S., Jacob R., Devignot S., Kochs G., et al. Incoming RNA virus nucleocapsids containing a 5'-triphosphorylated genome activate RIG-I and antiviral signaling. Cell Host Microbe 2013, 13:336-346.
15. Li X.D., Chiu Y.H., Ismail A.S., Behrendt C.L., Wight-Carter M., Hooper L.V., Chen Z.J. Mitochondrial antiviral signaling protein (MAVS) monitors commensal bacteria and induces an immune response that prevents experimental colitis. Proc Natl Acad Sci U S A 2011, 108:17390-17395.
16. Abdullah Z., Schlee M., Roth S., Mraheil M.A., Barchet W., Bottcher J., Hain T., Geiger S., Hayakawa Y., Fritz J.H., et al. RIG-I detects infection with live Listeria by sensing secreted bacterial nucleic acids. EMBO J 2012, 31:4153-4164.
17. Takahasi K., Yoneyama M., Nishihori T., Hirai R., Kumeta H., Narita R., Gale M., Inagaki F., Fujita T. Nonself RNA-sensing mechanism of RIG-I helicase and activation of antiviral immune responses. Mol Cell 2008, 29:428-440.
18. Marques J.T., Devosse T., Wang D., Zamanian-Daryoush M., Serbinowski P., Hartmann R., Fujita T., Behlke M.A., Williams B.R. A structural basis for discriminating between self and nonself double-stranded RNAs in mammalian cells. Nat Biotechnol 2006, 24:559-565.
19. Kato H., Takeuchi O., Mikamo-Satoh E., Hirai R., Kawai T., Matsushita K., Hiiragi A., Dermody T.S., Fujita T., Akira S. Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J Exp Med 2008, 205:1601-1610.
20. Binder M., Eberle F., Seitz S., Mucke N., Huber C.M., Kiani N., Kaderali L., Lohmann V., Dalpke A., Bartenschlager R. Molecular mechanism of signal perception and integration by the innate immune sensor retinoic acid-inducible gene-I (RIG-I). J Biol Chem 2011, 286:27278-27287.
21. Zeng W., Sun L., Jiang X., Chen X., Hou F., Adhikari A., Xu M., Chen Z.J. Reconstitution of the RIG-I pathway reveals a signaling role of unanchored polyubiquitin chains in innate immunity. Cell 2010, 141:315-330.
22. Kolakofsky D., Kowalinski E., Cusack S. A structure-based model of RIG-I activation. RNA 2012, 18:2118-2127.
23. Jiang Q.X., Chen Z.J. Structural insights into the activation of RIG-I, a nanosensor for viral RNAs. EMBO Rep 2012, 13:7-8.
24. Cui S., Eisenacher K., Kirchhofer A., Brzozka K., Lammens A., Lammens K., Fujita T., Conzelmann K.K., Krug A., Hopfner K.P. The C-terminal regulatory domain is the RNA 5'-triphosphate sensor of RIG-I. Mol Cell 2008, 29:169-179.
25. Wang Y., Ludwig J., Schuberth C., Goldeck M., Schlee M., Li H., Juranek S., Sheng G., Micura R., Tuschl T., et al. Structural and functional insights into 5'-ppp RNA pattern recognition by the innate immune receptor RIG-I. Nat Struct Mol Biol 2010, 17:781-787.
26. Lu C., Xu H., Ranjith-Kumar C.T., Brooks M.T., Hou T.Y., Hu F., Herr A.B., Strong R.K., Kao C.C., Li P. The structural basis of 5' triphosphate double-stranded RNA recognition by RIG-I C-terminal domain. Structure 2010, 18:1032-1043.
27. Lu C., Ranjith-Kumar C.T., Hao L., Kao C.C., Li P. Crystal structure of RIG-I C-terminal domain bound to blunt-ended double-strand RNA without 5' triphosphate. Nucleic Acids Res 2011, 39:1565-1575.
28. Kowalinski E., Lunardi T., McCarthy A.A., Louber J., Brunel J., Grigorov B., Gerlier D., Cusack S. Structural basis for the activation of innate immune pattern-recognition receptor RIG-I by viral RNA. Cell 2011, 147:423-435.
29. Civril F., Bennett M., Moldt M., Deimling T., Witte G., Schiesser S., Carell T., Hopfner K.P. The RIG-I ATPase domain structure reveals insights into ATP-dependent antiviral signalling. EMBO Rep 2011, 12:1127-1134.
30. Ferrage F., Dutta K., Nistal-Villan E., Patel J.R., Sanchez-Aparicio M.T., De Ioannes P., Buku A., Aseguinolaza G.G., Garcia-Sastre A., Aggarwal A.K. Structure and dynamics of the second CARD of human RIG-I provide mechanistic insights into regulation of RIG-I activation. Structure 2012, 20:2048-2061.
31. Jiang F., Ramanathan A., Miller M.T., Tang G.Q., Gale M., Patel S.S., Marcotrigiano J. Structural basis of RNA recognition and activation by innate immune receptor RIG-I. Nature 2011, 479:423-427.
32. Luo D., Ding S.C., Vela A., Kohlway A., Lindenbach B.D., Pyle A.M. Structural insights into RNA recognition by RIG-I. Cell 2011, 147:409-422.
33. Luo D., Kohlway A., Vela A., Pyle A.M. Visualizing the determinants of viral RNA recognition by innate immune sensor RIG-I. Structure 2012, 20:1983-1988.
34. Wu B., Peisley A., Richards C., Yao H., Zeng X., Lin C., Chu F., Walz T., Hur S. Structural basis for dsRNA recognition, filament formation, and antiviral signal activation by MDA5. Cell 2013, 152:276-289.
35. Li X., Lu C., Stewart M., Xu H., Strong R.K., Igumenova T., Li P. Structural basis of double-stranded RNA recognition by the RIG-I like receptor MDA5. Arch Biochem Biophys 2009, 488:23-33.
36. Takahasi K., Kumeta H., Tsuduki N., Narita R., Shigemoto T., Hirai R., Yoneyama M., Horiuchi M., Ogura K., Fujita T., et al. Solution structures of cytosolic RNA sensor MDA5 and LGP2 C-terminal domains: identification of the RNA recognition loop in RIG-I-like receptors. J Biol Chem 2009, 284:17465-17474.
37. Rehwinkel J. Exposing viruses: RNA patterns sensed by RIG-I-like receptors. J Clin Immunol 2010, 30:491-495.
38. Kato H., Takeuchi O., Sato S., Yoneyama M., Yamamoto M., Matsui K., Uematsu S., Jung A., Kawai T., Ishii K.J., et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 2006, 441:101-105.
39. Gack M.U., Shin Y.C., Joo C.H., Urano T., Liang C., Sun L., Takeuchi O., Akira S., Chen Z., Inoue S., et al. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 2007, 446:916-920.
40. Jiang X., Kinch L.N., Brautigam C.A., Chen X., Du F., Grishin N.V., Chen Z.J. Ubiquitin-induced oligomerization of the RNA sensors RIG-I and MDA5 activates antiviral innate immune response. Immunity 2012, 36:959-973.
41. Hou F., Sun L., Zheng H., Skaug B., Jiang Q.X., Chen Z.J. MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response. Cell 2011, 146:448-461.
42. Kagan J.C. Defining the subcellular sites of innate immune signal transduction. Trends Immunol 2012, 33:442-448.
43. Dixit E., Boulant S., Zhang Y., Lee A.S., Odendall C., Shum B., Hacohen N., Chen Z.J., Whelan S.P., Fransen M., et al. Peroxisomes are signaling platforms for antiviral innate immunity. Cell 2010, 141:668-681.
44. Horner S.M., Liu H.M., Park H.S., Briley J., Gale M. Mitochondrial-associated endoplasmic reticulum membranes (MAM) form innate immune synapses and are targeted by hepatitis C virus. Proc Natl Acad Sci U S A 2011, 108:14590-14595.
45. Daffis S., Szretter K.J., Schriewer J., Li J., Youn S., Errett J., Lin T.Y., Schneller S., Zust R., Dong H., et al. 2'-O methylation of the viral mRNA cap evades host restriction by IFIT family members. Nature 2010, 468:452-456.
46. Fensterl V., Wetzel J.L., Ramachandran S., Ogino T., Stohlman S.A., Bergmann C.C., Diamond M.S., Virgin H.W., Sen G.C. Interferon-induced Ifit2/ISG54 protects mice from lethal VSV neuropathogenesis. PLoS Pathog 2012, 8:e1002712.
47. Szretter K.J., Daniels B.P., Cho H., Gainey M.D., Yokoyama W.M., Gale M., Virgin H.W., Klein R.S., Sen G.C., Diamond M.S. 2'-O methylation of the viral mRNA cap by West Nile virus evades ifit1-dependent and -independent mechanisms of host restriction in vivo. PLoS Pathog 2012, 8:e1002698.
48. Zust R., Cervantes-Barragan L., Habjan M., Maier R., Neuman B.W., Ziebuhr J., Szretter K.J., Baker S.C., Barchet W., Diamond M.S., et al. Ribose 2'-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5. Nat Immunol 2011, 12:137-143.
49. Katibah G.E., Lee H.J., Huizar J.P., Vogan J.M., Alber T., Collins K. tRNA binding, structure, and localization of the human interferon-induced protein IFIT5. Mol Cell 2013, 49:743-750.
50. Yang Z., Liang H., Zhou Q., Li Y., Chen H., Ye W., Chen D., Fleming J., Shu H., Liu Y. Crystal structure of ISG54 reveals a novel RNA binding structure and potential functional mechanisms. Cell Res 2012, 22:1328-1338.
51. Knipe D.M., Howley P.M. Fields Virology 2007, Lippincott Williams & Wilkins, Philadelphia. edn 5.
52. Habjan M., Andersson I., Klingstrom J., Schumann M., Martin A., Zimmermann P., Wagner V., Pichlmair A., Schneider U., Muhlberger E., et al. Processing of genome 5' termini as a strategy of negative-strand RNA viruses to avoid RIG-I-dependent interferon induction. PLoS One 2008, 3:e2032.
53. Versteeg G.A., Garcia-Sastre A. Viral tricks to grid-lock the type I interferon system. Curr Opin Microbiol 2010, 13:508-516.
54. Andrejeva J., Norsted H., Habjan M., Thiel V., Goodbourn S., Randall R.E. ISG56/IFIT1 is primarily responsible for interferon-induced changes to patterns of parainfluenza virus type 5 transcription and protein synthesis. J Gen Virol 2013, 94:59-68.